Arrow Mark Colorado Holdings LLC Nektar Therapeutics Call Options Transaction History

Arrow Mark Colorado Holdings LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2018 Feb 14, 2019	SELL	$30.43 - $56.65 $3.04 Million - $5.67 Million	-100,000 Reduced 66.67%	50,000 $1.64 Million
Q3 2018 Nov 14, 2018	BUY	$46.46 - $68.49 $4.65 Million - $6.85 Million	100,000 Added 200.0%	150,000 $9.14 Million
Q2 2018 Aug 14, 2018	BUY	$46.25 - $104.45 $2.31 Million - $5.22 Million	50,000 New	50,000 $2.44 Million

146

139M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $204M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.